Choosing an antianginal therapy strategy in patients with stable coronary artery disease in real clinical practice: the advantages of trimetazidine

Cardiovascular diseases (CVD) are the leading cause of death among adults worldwide, including in the Russian Federation. At the same time, the leading position in the structure of causes of death from CVD is occupied by coronary heart disease (CHD) (16% of the total number of deaths in the world pe...

Full description

Bibliographic Details
Main Authors: E. V. Borisova, O. D. Ostroumova, A. P. Pereverzev, E. E. Pavleeva
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-09-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/6328